Tom 16, Nr 2 (2020)
Obrazy w medycynie
Opublikowany online: 2020-06-03
Wyświetlenia strony
1438
Wyświetlenia/pobrania artykułu
382
Postać guzowa stwardnienia rozsianego
1
Pol. Przegl. Neurol 2020;16(2):121-122.
Streszczenie
Brak
Słowa kluczowe: stwardnienie rozsianepostać guzowaguzowa plaka demielinizacyjna
Referencje
- Lucchinetti CF, Gavrilova RH, Metz I, et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008; 131(Pt 7): 1759–1775.
- Abou Zeid N, Pirko I, Erickson B, et al. Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions. Neurology. 2012; 78(21): 1655–1662.
- Fargeot G, Aboab J, Savatovsky J, et al. Central nervous system aquaporin4 autoimmunity revealed by a single pseudotumoral encephalic lesion. Metab Brain Dis. 2018; 33(1): 353–355.
- Miyaue N, Yamanishi Y, Tada S, et al. A case of ADEM-like presentation with anti-MOG antibody following tumefactive demyelinating lesion. Mult Scler Relat Disord. 2019; 31: 62–64.
- Navardi S, Sahraian MA, Naser Moghadasi A. Tumefactive demyelinating lesions after initiating fingolimod in patient with multiple sclerosis: A case report. Rev Neurol (Paris). 2020; 176(4): 289–290.
- Sánchez P, Meca-Lallana V, Vivancos J. Tumefactive multiple sclerosis lesions associated with fingolimod treatment: Report of 5 cases. Mult Scler Relat Disord. 2018; 25: 95–98.
